Current years Studies have claimed now that Pomegranate juice can prevent from happening several complications in kidney disease patients on dialysis, including the high morbidity rate due to infections and cardiovascular events.
A study on 101 dialysis patients who received either pomegranate juice or another placebo drink at the beginning of each dialysis session, three times a week for one year.
Laboratory tests showed that patients who drank pomegranate juice experienced reduced inflammation and the damage of oxidative stress caused by free radicals was reduced.
Recent analysis of data revealed that those who drank pomegranate juice showed an improvement in cardiovascular risk factors, such as reduced blood pressure, improvement in lipid profile and fewer cardiovascular events, suggesting that they had better heart health. These results are in agreement with other studied populations and particularly important for hemodialysis patients, because most kidney disease patients die either from cardiovascular-related causes or infections.
Pomegranate juice with a safe and check content of potassium may help and reduce the complications that often occur in dialysis patients. It is important to consider the risk involved in potassium overload, especially in chronic kidney disease (CKD) patients with dietary potassium restriction.
Lead researcher Dr Batya Kristal of the Western Galilee Hospital said that considering the expected epidemic of CKD in the next decade, further clinical trials using pomegranate juice aimed at reducing the high cardiovascular morbidity of CKD patients and their deterioration to end-stage renal disease should be conducted.